跳至主要内容
临床试验/JPRN-UMIN000015319
JPRN-UMIN000015319招募中未知

The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome - The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome

Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology0 个研究点目标入组 20 人开始时间: 2014年10月12日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional,observational

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) patients with Child-Pugh classification C 2) patients with severe cardiac or pulmonary dysfunction 3) patients with hemoglobin A1c > 6.5 4) patients with treatment history of dabigatran 5) patients who need treatment of dabigatran combined with other anticoagulant or antiplatelet agent 6) patients with creatinine clearance < 50 ml/min 7) patients who have bleeding symptom or hemophliac 8) patients with peptic ulcers 9) patients with history of cerebral bleeding within 6 months 10) patients with epidural catheter 11) patients with use of non-steroidal anti-inflammatory drugs 12) patients with use of P-glycoprotein repressor 13) patients with use of itoraconazole 14) patients using cardiac pacemaker 15) pregnant woman

研究者

发起方
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology

相似试验

招募中
不适用
Efficacy and Safety of Dabigatran for Thromboprophylaxis after Total Knee or Hip Arthroplasty : a pilot studyprimary knee or hip arthroplastyTKA&#44THA&#44Dabigatran&#44DVT&#44PE
TCTR20150504001Golden Jubilee Medical Center32
招募中
不适用
Efficacy and Safety of Dabigatran for Thromboprophylaxis after Total Knee Arthroplastypatients underwent knee replacement surgerydabigatran&#44deep vein thrombosis&#44pulmonary embolism&#44new oral anticoagulant&#44prophylaxis&#44knee replacement&#44Asian
TCTR20160208001Golden Jubilee Medical Center&#44; Mahidol University32
招募中
3 期
efficacy and safety of dabigatran(paradxa) in pediatric thromboembolism Referring to Amir Kabir Hospital in Arakchildren-thromboemboli.Embolism and thrombosis of other arteries
IRCT20180711040431N1Arak University of Medical Sciences20
进行中(未招募)
1 期
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary InterventionMedDRA version: 20.0Level: PTClassification code 10051592Term: Acute coronary syndromeSystem Organ Class: 10007541 - Cardiac disorders
EUCTR2020-004887-24-PLMarcin Gruchala Medical University of Gdansk2,230
Unknown
4 期
Dabigatran in Patients With Atrial Fibrillation and Mitral Biological ProsthesesMitral Valve Stenosis and InsufficiencyAtrial Fibrillation
NCT03183843Research Institute for Complex Problems of Cardiovascular Diseases, Russia40